Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMSACRINE for Bone marrow conditioning regimen: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 84 adverse event reports in the FDA FAERS database where AMSACRINE was used for Bone marrow conditioning regimen.

Most Reported Side Effects for AMSACRINE

Side Effect Reports % Deaths Hosp.
Off label use 47 10.3% 14 27
Death 46 10.1% 46 1
Septic shock 41 9.0% 34 16
Multiple organ dysfunction syndrome 40 8.8% 32 23
Acute myeloid leukaemia recurrent 39 8.5% 34 2
Venoocclusive liver disease 36 7.9% 12 19
Drug ineffective 35 7.7% 16 13
Febrile neutropenia 33 7.2% 0 20
Graft versus host disease 33 7.2% 21 18
Neutropenia 32 7.0% 22 20
Drug resistance 30 6.6% 8 19
Gastrointestinal disorder 28 6.1% 14 13
Bronchopulmonary aspergillosis 27 5.9% 8 9
Graft versus host disease in gastrointestinal tract 26 5.7% 14 15
Product use in unapproved indication 25 5.5% 9 5

Other Indications for AMSACRINE

Acute myeloid leukaemia (240) Product used for unknown indication (31) Stem cell transplant (16) Chronic myelomonocytic leukaemia (14) Myelodysplastic syndrome (12) Bone marrow transplant (11) Chemotherapy (11) Acute leukaemia (10) Chronic myeloid leukaemia (8) Allogenic stem cell transplantation (6)

Other Drugs Used for Bone marrow conditioning regimen

FLUDARABINE (6,080) BUSULFAN (4,669) CYCLOPHOSPHAMIDE (4,485) MELPHALAN (2,368) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884) THIOTEPA (1,551) ALEMTUZUMAB (1,122) ETOPOSIDE (936) CYTARABINE (833) THYMOCYTE IMMUNE GLOBULIN NOS (742)

Related Pages

AMSACRINE Full Profile All Bone marrow conditioning regimen Drugs AMSACRINE Demographics AMSACRINE Timeline